Real-time enrollment status for this esophageal squamous cell carcinoma clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 3:12 PM UTC
| NCT Number | NCT06780111 |
| Recruiting Status | Recruiting |
| Condition | Esophageal Squamous Cell Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 298 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | August 25, 2026 (2 days ago) |
As of August 27, 2026: Clinical trial NCT06780111 is currently recruiting participants. This phase1 study for esophageal squamous cell carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06780111 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06780111 was last updated 2 days ago (August 25, 2026). HelloStudys verifies this status automatically.